Enhancement of hypoxia-activated prodrug TH-302 anti-tumor activity by Chk1 inhibition

por Meng, Fanying, Bhupathi, Deepthi, Sun, Jessica D, Liu, Qian, Ahluwalia, Dharmendra, Wang, Yan, Matteucci, Mark D, Hart, Charles P
Publicado 2015

Efficacy and safety of the hypoxia-activated prodrug TH-302 in combination with gemcitabine and nab-paclitaxel in human tumor xenograft models of pancreatic cancer

por Sun, Jessica D, Liu, Qian, Ahluwalia, Dharmendra, Li, Wenwu, Meng, Fanying, Wang, Yan, Bhupathi, Deepthi, Ruprell, Ayesha S, Hart, Charles P
Publicado 2015

Hypoxia-Targeting Drug Evofosfamide (TH-302) Enhances Sunitinib Activity in Neuroblastoma Xenograft Models()

por Kumar, Sushil, Sun, Jessica D., Zhang, Libo, Mokhtari, Reza Bayat, Wu, Bing, Meng, Fanying, Liu, Qian, Bhupathi, Deepthi, Wang, Yan, Yeger, Herman, Hart, Charles, Baruchel, Sylvain
Publicado 2018